FIELD: medicine.
SUBSTANCE: present invention refers to medicine, namely urology, and can be used to detect urinary tract infection in the patient. Method involves obtaining a sample from the patient and detection in the above sample CD1d receptor expression on NKT-cells and BCL6 in bladder tissues. Higher expression of CD1d on NKT-cells and reduction of BCL6 in tissues of the bladder is diagnosed infection urinary tract.
EFFECT: using the given biomarkers enables diagnosing the presence of infection urinary tract diseases, as well as use for estimating clinical effectiveness.
1 cl, 1 ex, 7 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| DIAGNOSTIC METHOD OF AN INFLAMMATORY PROCESS OF URINARY SYSTEM IN YOUNG CHILDREN | 2018 |
|
RU2679629C1 |
| MOLECULAR MARKERS FOR URINARY TRACT INFECTIONS | 2011 |
|
RU2611371C2 |
| THERAPEUTIC, DIAGNOSTIC AND PROGNOSTIC METHODS FOR BLADDER CANCER | 2015 |
|
RU2739942C2 |
| METHOD OF ESTIMATING EFFICIENCY OF THERAPY OF URINARY BLADDER CANCER BY MEANS OF ONCOMARKER NUSAP1 | 2011 |
|
RU2468372C1 |
| METHOD FOR PREDICTION OF THE RISK OF DEVELOPING WEB-ASSOCIATED TUMORS IN THE PATIENTS WITH ACUTE EBV-INFECTION | 2019 |
|
RU2707075C1 |
| METHOD FOR DIAGNOSING URINARY TRACT INFECTION IN INFANTS AND YOUNG CHILDREN | 2020 |
|
RU2739222C1 |
| METHOD OF ESTIMATING EFFICIENCY OF THERAPY URINARY BLADDER CANCER IN HUMANS BY METHOD OF IMMUNOFERMENTATIVE ANALYSIS | 2011 |
|
RU2468088C1 |
| METHOD OF DIAGNOSING URINARY BLADDER CANCER BY MEANS OF ONCOMARKER KIFC1 (VERSIONS) AND SET FOR ITS REALISATION | 2011 |
|
RU2470301C2 |
| BIOMARKER | 2009 |
|
RU2573925C2 |
| METHODS AND COMPOSITIONS FOR TREATMENT OF PERSISTENT INFECTIONS | 2016 |
|
RU2746383C2 |
